- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Bayer's Mason joins GE service effort
Former Agfa technical imaging chief Caren Mason has left a newposition at Agfa's parent company Bayer for a job in the serviceorganization of GE Medical Systems. Mason had been in the Bayerposition for only a matter of weeks before she accepted the
Former Agfa technical imaging chief Caren Mason has left a newposition at Agfa's parent company Bayer for a job in the serviceorganization of GE Medical Systems. Mason had been in the Bayerposition for only a matter of weeks before she accepted the jobwith the Milwaukee company.
Mason had led Agfa's Ridgefield Park, NJ, technical imaging divisionsince 1994, overseeing the unit's development into one of theindustry's most successful suppliers of PACS equipment. She waspromoted last month to a new position at Bayer as senior vicepresident of Bayer Corporate Healthcare (SCAN 6/19/96).
At GE, Mason has been named general manager of the southeasternservice zone and will be based in Atlanta, according to Tom Dunham,vice president and general manager of GE's service division.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
